2026-2030年全球細胞培養市場

全球細胞培養市場預計將從 2025 年到 2030 年成長至 285.279 億美元，預測期內複合年成長率為 12.7%。

這份關於全球細胞培養市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新市場趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：生物製藥和單株抗體需求的成長、細胞和基因療法商業化的加​​速以及自動化和即時代謝監測技術的普及。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場分析及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

本研究指出， 3D細胞培養系統和晶片器官技術是未來幾年全球細胞培養市場成長的關鍵促進因素。此外，無動物源和化學成分明確的培養基的普及，以及引入先進的一次性生物反應器而擴大的全球生物加工能力，預計也將產生巨大的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球細胞培養市場
• 產品細分市場分析，2020-2024 年
• 2020-2024 年最終用戶細分市場分析
• 基於應用領域的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球細胞培養市場
• 地緣政治衝突對全球細胞培養市場的影響。

第7章：五力分析

第8章 市場區隔：依產品

• 比較：按產品
• 消耗品
• 裝置
• 市場機會：依產品分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 製藥和生物技術公司
• 醫院
• 研究和學術機構
• 其他
• 市場機會：依最終用戶分類

第10章 市場區隔：依應用

• 比較：透過應用
• 生物製藥生產
• 藥物發現
• 組織培養及組織工程
• 診斷
• 其他
• 市場機會：依應用領域分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 泰國
  • 印尼
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • 阿根廷
  • UAE
  • 南非
  • 以色列
  • 哥倫比亞
  • 土耳其
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 中斷狀況
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Agilent Technologies Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• Bio Techne Corp.
• Corning Inc.
• Cytiva
• Eppendorf SE
• Evonik Industries AG
• Getinge AB
• Lonza Group Ltd.
• Promega Corp.
• Repligen Corp.
• Revvity Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.

第16章附錄

The global cell culture market is forecasted to grow by USD 28527.9 mn during 2025-2030, accelerating at a CAGR of 12.7% during the forecast period. The report on the global cell culture market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for biopharmaceuticals and monoclonal antibodies, accelerated commercialization of cell and gene therapies, proliferation of automation and real-time metabolic monitoring.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cell culture market is segmented as below:

By Product

• Consumables
• Equipment

By End-User

• Pharma and biotech companies
• Hospitals
• Research and academic institutes
• Others

By Application

• Biopharmaceutical production
• Drug discovery
• Tissue culture and engineering
• Diagnostics
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the three-dimensional culture systems and organ-on-chip technologies as one of the prime reasons driving the global cell culture market growth during the next few years. Also, mainstream transition toward animal component-free and chemically defined media and escalation of global bioprocessing capacity via advanced single-use bioreactor implementations will lead to sizable demand in the market.

The report on the global cell culture market covers the following areas:

• Global cell culture market sizing
• Global cell culture market forecast
• Global cell culture market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cell culture market vendors that include Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., BioIVT LLC, Biological Industries, Corning Inc., Cytiva, Eppendorf SE, Evonik Industries AG, FUJIFILM Irvine Scientific Inc., Getinge AB, HiMedia Laboratories Pvt. Ltd., Lonza Group Ltd., Promega Corp., Repligen Corp., Revvity Inc., STEMCELL Technologies Inc., Tecan Trading AG, Thermo Fisher Scientific Inc.. Also, the global cell culture market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cell Culture Market 2020 - 2024
  • Historic Market Size - Data Table on Global Cell Culture Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Cell Culture Market
• 6.2 Impact of geopolitical conflicts on Global Cell Culture Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Consumables - Market size and forecast 2025-2030
• 8.4 Equipment - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Pharma and biotech companies - Market size and forecast 2025-2030
• 9.4 Hospitals - Market size and forecast 2025-2030
• 9.5 Research and academic institutes - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Biopharmaceutical production - Market size and forecast 2025-2030
• 10.4 Drug discovery - Market size and forecast 2025-2030
• 10.5 Tissue culture and engineering - Market size and forecast 2025-2030
• 10.6 Diagnostics - Market size and forecast 2025-2030
• 10.7 Others - Market size and forecast 2025-2030
• 10.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 Argentina - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Israel - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising demand for biopharmaceuticals and monoclonal antibodies
  • Accelerated commercialization of cell and gene therapies
  • Proliferation of automation and real-time metabolic monitoring
• 13.2 Market challenges
  • Vulnerability of supply chains for highly specialized biological consumables
  • Contamination risks and extreme financial liabilities of batch failures
  • High capital expenditures and changing global regulatory compliance standards
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Three-dimensional culture systems and organ-on-chip technologies
  • Mainstream transition toward animal component-free and chemically defined media
  • Escalation of global bioprocessing capacity via advanced single-use bioreactor implementations

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.6 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.7 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
  • SWOT
• 15.8 Corning Inc.
  • Corning Inc. - Overview
  • Corning Inc. - Business segments
  • Corning Inc. - Key offerings
  • Corning Inc. - Segment focus
  • SWOT
• 15.9 Cytiva
  • Cytiva - Overview
  • Cytiva - Product / Service
  • Cytiva - Key offerings
  • SWOT
• 15.10 Eppendorf SE
  • Eppendorf SE - Overview
  • Eppendorf SE - Product / Service
  • Eppendorf SE - Key offerings
  • SWOT
• 15.11 Evonik Industries AG
  • Evonik Industries AG - Overview
  • Evonik Industries AG - Business segments
  • Evonik Industries AG - Key offerings
  • Evonik Industries AG - Segment focus
  • SWOT
• 15.12 Getinge AB
  • Getinge AB - Overview
  • Getinge AB - Business segments
  • Getinge AB - Key offerings
  • Getinge AB - Segment focus
  • SWOT
• 15.13 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
  • SWOT
• 15.14 Promega Corp.
  • Promega Corp. - Overview
  • Promega Corp. - Product / Service
  • Promega Corp. - Key offerings
  • SWOT
• 15.15 Repligen Corp.
  • Repligen Corp. - Overview
  • Repligen Corp. - Product / Service
  • Repligen Corp. - Key offerings
  • SWOT
• 15.16 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.17 STEMCELL Technologies Inc.
  • STEMCELL Technologies Inc. - Overview
  • STEMCELL Technologies Inc. - Product / Service
  • STEMCELL Technologies Inc. - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations